From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
The trial builds off the company’s previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback